Skip to main content

Basel is the most popular Swiss location for headquarters

Novartis Campus
| News

Basel is the most popular Swiss location for headquarters

23.04.2020

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Novartis Campus
Novartis global headquarter in Basel (img: Mark Niedermann)

Last year, 912 international companies established their headquarters abroad according to an article by fDi Intelligence on the new rankings. fDi Intelligence has listed the top 30 European locations for headquarters in relation to the number of inhabitants based on the figures. While first place is taken by Dublin, Basel is the best-placed Swiss city at number eight. Geneva is also listed in 19th place.

The list generally illustrates the prevailing position of sites in the United Kingdom. As such, after Dublin and Amsterdam, come Reading and Warwick. Galway in Ireland takes fifth place above Vantaa in Finland. Cork in Ireland (7th), London (9th) and Luxembourg round off the top ten. Munich (17th), Dusseldorf (20th) and Frankfurt (29th) are other German-speaking cities to make it into the top 30.

Data from 2015 to 2019 was considered to create the list. For this, the investments required to establish the headquarters per 100,000 inhabitants of the respective city were used as well as other capital investments and the creation of jobs per 100,000 inhabitants.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.